Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activity

Several agents targeting the epidermal growth factor receptor (EGFR) have been FDA-approved to treat cancer patients with varying tumor types including metastatic colorectal cancer. Many patients treated with anti-EGFR therapy however do not respond and those that do initially respond often acquire...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ung, Nelson, Putoczki, Tracy L, Stylli, Stanley S, Ng, Irvin, Mariadason, John M, Chan, Timothy A, Zhu, Hong-Jian, Luwor, Rodney B
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2014
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4026085/
https://ncbi.nlm.nih.gov/pubmed/24556630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.28179
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars